Physician profile
Christopher N Webb
NPI 1629365853
$1,910.25
in general payments reported to CMS, 2019-2025
16 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $391 · 2021: $264 · 2022: $136 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $635.20 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $410.19 | 2019-2025 | Ozempic |
| Glaxosmithkline, LLC. | $157.25 | 2019-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $154.89 | 2020-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $117.76 | 2019-2025 | |
| Amgen INC. | $101.45 | 2019-2025 | Evenity, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $97.75 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.29 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $41.10 | 2019 | |
| Pfizer INC. | $29.37 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.69 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $20.41 | 2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.38 | 2025 | Caplyta |
| Sanofi Pasteur INC. | $14.95 | 2019 | |
| Allergan, INC. | $14.57 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.